HK1170665A1 - 高血壓或正常高值血壓的治療藥 - Google Patents

高血壓或正常高值血壓的治療藥

Info

Publication number
HK1170665A1
HK1170665A1 HK12111428.5A HK12111428A HK1170665A1 HK 1170665 A1 HK1170665 A1 HK 1170665A1 HK 12111428 A HK12111428 A HK 12111428A HK 1170665 A1 HK1170665 A1 HK 1170665A1
Authority
HK
Hong Kong
Prior art keywords
hypertension
therapeutic agent
blood pressure
high blood
normal high
Prior art date
Application number
HK12111428.5A
Other languages
English (en)
Inventor
Takashi Shirakura
Mizuho Tamura
Yoshimasa Takahashi
Ippei Kuwahara
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of HK1170665A1 publication Critical patent/HK1170665A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12111428.5A 2009-06-26 2012-11-12 高血壓或正常高值血壓的治療藥 HK1170665A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22071709P 2009-06-26 2009-06-26
PCT/JP2010/061301 WO2010150921A1 (ja) 2009-06-26 2010-06-25 高血圧症または正常高値血圧症の治療薬

Publications (1)

Publication Number Publication Date
HK1170665A1 true HK1170665A1 (zh) 2013-03-08

Family

ID=43386687

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111428.5A HK1170665A1 (zh) 2009-06-26 2012-11-12 高血壓或正常高值血壓的治療藥

Country Status (13)

Country Link
US (1) US9545445B2 (zh)
EP (1) EP2446885B1 (zh)
JP (1) JP5753082B2 (zh)
KR (1) KR20120096920A (zh)
CN (1) CN102458401B (zh)
AU (1) AU2010263549B2 (zh)
BR (1) BRPI1011456A2 (zh)
CA (1) CA2764597A1 (zh)
HK (1) HK1170665A1 (zh)
MX (1) MX2011013541A (zh)
RU (1) RU2539382C2 (zh)
TW (1) TW201113019A (zh)
WO (1) WO2010150921A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081935A1 (es) * 2010-06-16 2012-10-31 Teijin Pharma Ltd Tableta con nucleo recubierto de liberacion controlada
KR101710441B1 (ko) 2015-12-28 2017-02-28 신풍제약주식회사 안정성 및 용출성이 향상된 정제
CN112341467B (zh) * 2020-11-13 2022-09-27 中国科学院海洋研究所 一种二酮哌嗪生物碱类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513379T3 (da) 1990-11-30 1996-09-30 Teijin Ltd 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
US6224474B1 (en) * 1999-01-06 2001-05-01 Buehler, Ltd. Magnetic disc system for grinding or polishing specimens
DE60137635D1 (de) * 2000-06-28 2009-03-26 Merck & Co Inc Verwendung von allopurinol zur behandlung von bluthochdruck
EP1940397A4 (en) 2005-08-03 2010-01-20 Takeda Pharmaceuticals North A METHOD FOR TREATING HYPERTONIA
US20080227980A1 (en) 2005-08-05 2008-09-18 Novartis Ag Preparation of a 7H-Pyrrolo [2,3-D] Pyrimidine Derivative
US8501750B2 (en) 2007-05-21 2013-08-06 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof

Also Published As

Publication number Publication date
CN102458401A (zh) 2012-05-16
KR20120096920A (ko) 2012-08-31
EP2446885A4 (en) 2012-12-19
RU2012102518A (ru) 2013-08-10
JPWO2010150921A1 (ja) 2012-12-10
TW201113019A (en) 2011-04-16
EP2446885A1 (en) 2012-05-02
BRPI1011456A2 (pt) 2016-03-15
AU2010263549A1 (en) 2011-12-15
AU2010263549B2 (en) 2014-10-30
CN102458401B (zh) 2015-09-16
RU2539382C2 (ru) 2015-01-20
MX2011013541A (es) 2012-02-21
JP5753082B2 (ja) 2015-07-22
US20110046192A1 (en) 2011-02-24
EP2446885B1 (en) 2017-09-06
WO2010150921A1 (ja) 2010-12-29
US9545445B2 (en) 2017-01-17
CA2764597A1 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
HK1223025A1 (zh) 組織閉塞劑
GB2448582B (en) Non-invasive blood pressure determination method
EP3875137C0 (en) INFLATABLE MEDICAL DEVICES
EP2506802A4 (en) NON-INVASIVE IMPLANT RIP DETECTION SYSTEM
EP2338457A4 (en) MEDICAL BED
EP2398403A4 (en) INTEGRATED FASTENING SYSTEM
EP2301560A4 (en) PHARMACEUTICAL AGENT FOR PROMOTING THE FUNCTIONAL REGENERATION OF DEGRADED TISSUE
HK1171682A1 (zh) 鼻炎治療劑
IL216081A (en) Pharmacological preparation for reducing intraocular pressure
GB0915948D0 (en) Surgical, therapeutic or diagnostic tool
IL209006A0 (en) Therapeutic agent for male sterility
PL2473101T3 (pl) Urządzenie do nieinwazyjnego określania ciśnienia tętniczego krwi
EP2500020A4 (en) THERAPEUTIC OR PROPHYLACTIC ACTIVE AGAINST DIABETES
HK1150966A1 (zh) 異常眼內壓治療
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
GB0900484D0 (en) Therapeutic agent
HK1170665A1 (zh) 高血壓或正常高值血壓的治療藥
EP1983893A4 (en) VOLTAGE MEASURING APPARATUS
HK1170277A1 (zh) 藥劑盒
IL219840A0 (en) Alkaline alpha galactosidase for the treatment of fabry disease
PL2319454T3 (pl) Urządzenie bajpasujące do wpływania na ciśnienie krwi
GB0908425D0 (en) Medical use
EP2029006A4 (en) BLOOD PRESSURE MONITOR
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
EP2412705A4 (en) NEW THERAPEUTIC AGENT FOR COGNITIVE DEFICIT

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190628